DBVT (DBV Technologies S.A.) Stock Analysis - Hedge Fund Holdings
DBV Technologies S.A. (DBVT) is a publicly traded Healthcare sector company. As of May 20, 2026, DBVT trades at $18.49 with a market cap of $1.11B and a P/E ratio of -17.67. DBVT moved +0.49% today. Year to date, DBVT is +9.12%; over the trailing twelve months it is +93.13%. Its 52-week range spans $2.20 to $26.19. Analyst consensus is buy with an average price target of $40.97. Rallies surfaces DBVT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns DBVT stock?
Hedge funds tracked by Rallies that own DBVT include Redmile Group and Duquesne Family. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for DBV Technologies S.A..
DBVT Key Metrics
Key financial metrics for DBVT
Metric
Value
Price
$18.49
Market Cap
$1.11B
P/E Ratio
-17.67
EPS
$-1.05
Dividend Yield
0.00%
52-Week High
$26.19
52-Week Low
$2.20
Volume
103.27K
Avg Volume
0
Revenue (TTM)
$5.64M
Net Income
$-146.95M
Gross Margin
0.00%
Top Hedge Funds Holding DBVT
Redmile Group holds 491.34K shares of DBVT, changed -10.64% as of Mar 31, 2026.
Duquesne Family holds 383.36K shares of DBVT, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own DBVT include Redmile Group and Duquesne Family. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for DBV Technologies S.A..
Does Rallies show 13F holders for DBVT?
Yes. Rallies tracks hedge fund and 13F ownership data for DBVT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is DBVT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DBVT. It does not provide personalized investment advice.
